Eli Lilly (LLY) leads with groundbreaking tirzepatide (Mounjaro/Zepbound), while Hims & Hers Health (HIMS) faces challenges.

Xeris Biopharma Holdings has received regulatory approval for a new use of its Gvoke liquid glucagon in gastrointestinal ... with one-count or 10-count single-dose vials available by the third ...

Both products are priced at a similar level to the glucagon injection kits available on the market ... soluble analogue works rapidly, with a single dose restoring normal glucose levels in ...

Glucose gel formulations are packaged in single-serve 15-gram tubes ... In December 2020, the FDA approved the first generic version of glucagon for injection. The product is packaged in an emergency ...

Universitätsmedizin Berlin has found that a single dose of the Imvanex vaccine provides protection against mpox with 84% effectiveness. For people with HIV, however, a single dose of the vaccine ...

Getty Images Lepodisiran — an experimental drug made by the pharmaceutical company Eli Lilly — has been found to slash this type of cholesterol by nearly 94% after a single dose. Participants ...

Gvoke VialDx has the potential to modernize the handling and administration of glucagon for diagnostic ... or 10-count package of 1 mg per 0.2 mL single-dose vials. Indications and Important ...

A single dose of an experimental drug dramatically reduced levels of a deadly form of cholesterol, often thought to be untreatable, for up to one year. Lipoprotein(a) is a type of cholesterol that ...